Singapore Diagnostics (SGD), one of the largest laboratories in the Philippines, has been re-accredited by the prestigious College of American Pathologists (CAP). Less than 500 international laboratories have received this accreditation.
“We are honored to receive the College of American Pathologists accreditation as a testament to the high quality of Singapore Diagnostics’ services and the work of our well-trained clinicians. This recognition will definitely inspire us to continue to offer world-class healthcare services that Filipinos can afford,” said Ritche Evidente, Singapore Diagnostics President and CEO.
Since its establishment in late 2013 in the Philippines, SGD has been processing laboratory requirements for over 500 hospitals, clinics, labs, and healthcare institutions in the country. Serving up to 50,000 patients every month and running up to 2.5 million laboratory examinations a year. The company is a subsidiary of Pathology Asia (PAH), which is among Southeast Asia’s large medical diagnostic groups with pathology, genomic, and digital health operations in Australia, Singapore, Malaysia, Indonesia, and Vietnam.
Singapore Diagnostics implements the highest quality control in their laboratory work, benchmarking all test results, not just against local quality standards, but against those of the best hospitals in the world. SGD offers a host of services, including serving as a referral or back-up for other labs and hospitals or providing full laboratory outsourcing, including improving personnel skills.
In its 9 years in the business, the company has served as the training ground for Filipino medical technologists and clinicians who are now working in top hospitals and health institutions all over the world.
Singapore Diagnostics will be building additional facilities nationwide for a total of 50 laboratories in the Philippines and now has 450 employees all over the country. In the end, Filipinos will have access to high quality healthcare in every major city in the country.